Efficacy and Tolerability of an Intra-Nasal Testosterone Product

NCT00975650 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadism

Interventions

DRUG: Nasobol®
DRUG: Androderm® (Positive Control)

Sponsor

Acerus Pharmaceuticals Corporation